Fiber Optic Technology for Intracranial Pressure Measurements

Dr. Sandor Beniczky will discuss the research, development, and validation of SCORE-AI. Dr. Harald Aurlien will deliver a detailed presentation of the clinical advantages of autoSCORE in LTM including in depth review of clinical case studies. Following the 45-minute presentation there will also be an opportunity for Q&A. This course is intended for Epileptologists, EEG Techs, and Researchers.

Learning Objectives:

• To understand the extensive validation process involved with SCORE-AI development
• To appreciate the potential clinical value of implementing AI in EEG
• To review specific case studies analysed by autoSCORE

This course is approved for 1.0 CEU by ASET – The Neurodiagnostic Society.

EEG plays a fundamental role in the management of comatose patients following cardiac arrest. Several EEG patterns are strongly associated with outcome and EEG is recommended as part of the multimodal prognostication paradigm. Periodic and rhythmic discharges are common in these patients. Some of them represent an opportunity for intervention.

Learning Objectives:

• To recognize the most common EEG patterns encountered in post-anoxic coma and their prognostic significance
• To discuss the role and limitations of reactivity testing in this setting
• To learn how to integrate EEG in the multimodal prognostication paradigm
• To review the evidence for the management of post-anoxic SE

This course is approved for 1.0 CEU by ASET – The Neurodiagnostic Society.

This presentation provides a comprehensive review of the 2025 ILAE updates to both the classification of epileptic seizures and epilepsy syndromes. The session will cover the taxonomic framework for seizure classification—including the use of consciousness as a classifier, the distinction between observable and non-observable seizure types, and the incorporation of newly recognized entities—as well as the updated approach to syndrome diagnosis across the lifespan. Emphasis will be placed on practical application in clinical care, with case-based examples illustrating how accurate seizure and syndrome classification inform etiology-driven diagnosis, therapeutic choices, and prognostic counseling. Considerations for use in resource-limited settings, research, and policy development will also be discussed.

Learning Objectives:

1. Summarize the 2025 ILAE operational classification of seizures and epilepsy syndromes, including the hierarchical structure and key terminology updates.
2. Differentiate seizure types using the revised criteria for consciousness, observable manifestations, and specific semiologic features.
3. Recognize the major electroclinical syndromes across neonate, infantile, childhood, adolescent, and adult onset groups, and understand their etiologic, prognostic, and therapeutic implications.
4. Integrate seizure classification with syndrome diagnosis to improve diagnostic precision, guide investigations (e.g., genetics, imaging), and inform treatment selection.
5. Apply the updated classifications to real-world clinical scenarios, research studies, and multidisciplinary care planning, including communication with patients, families, and policymakers.
6. Evaluate how these classification updates enhance global harmonization, support education, and align with precision medicine initiatives in epilepsy.

1.0 CEU is available through ASET